© PublicDomainPictures/Pixabay.

Webinar – Procurement of pharmaceuticals: How can buyers make more sustainable choices?

  • Health
  • Aid
  • Procurement
  • Medical items

Thursday 08 June 2023
1:00 – 2:30 pm (CET Geneva time)

About the webinar

Procurement of pharmaceuticals – How can buyers make more sustainable choices?

This webinar will discuss the current state of efforts in the pharmaceutical industry to reduce its carbon footprint and will provide actionable insights on how buying organisations can make a positive impact through sustainable procurement practices.

Dr. Amy Booth, University of Oxford, will summarise the findings of a paper she co-authored on the strategies of pharmaceutical companies to address climate change. Adam Ajzensztejn, Senior Director, ESG Reporting and Engagement at Teva Pharmaceuticals will present the approach of Teva Pharmaceuticals to reducing their carbon footprint and share their achievements thus far. BSI is convening the development of a standard to  drive consensus on an ecosystem-wide methodology standard for the calculation of carbon footprints of pharmaceutical products. Courtney Soulsby, Global Director, Healthcare and Life Sciences, will introduce the standards programme and its objectives.

The presentations will be followed by a Q&A session where we will explore further with the panellists what buying organisations can concretely do to reduce the environmental and carbon impact of the procurement of pharmaceuticals. Join us for this insightful discussion on sustainable medical procurement and learn how your organisation can procure pharmaceuticals with a lower impact.


When and where?

June 08, 2023 (Thursday) | 1.00 – 2.30 pm (CET Geneva time)


Language: this webinar will be held in English and translated simultaneously into French.



  • University of Oxford, Dr. Amy Booth, PhD researcher

Dr Amy Booth is a medical doctor, graduating from the University of Cape Town, South Africa. She is currently undertaking a PhD, as a Rhodes Scholar, at the University of Oxford, exploring the environmental impact of health systems. Her research focuses on exploring strategies to reduce greenhouse gas emissions across the pharmaceutical supply chain. She has several published peer-reviewed articles, has been invited to present on her research on both national and international platforms, and is part of the first cohort of the UK Young Academy.

Link to the paper

Speaker: Dr. Amy Booth


  • Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines for more than a century. Teva is a global leader in generic and innovative medicines with a portfolio consisting of over 2,300 products in nearly every therapeutic area, and serves around 200 million people every day. The company has set climate targets, which were recently validated by the Science Based Targets initiative (SBTi), and established plans to reduce greenhouse gas  emissions across its operations and value chain. Teva has issued Sustainability-Linked Bonds (SLB) to a total value of $7.5 billion (equivalent), making it the second largest SLB issuer in the world, and the largest of the pharmaceutical sector. These financing instruments link Teva’s ESG targets, that include improving access to Teva’s portfolio of medicines in low- and middle-income countries (LMICs) and reducing Teva’s absolute greenhouse gas  emissions.

Link to Teva’s impact website

Speaker: Adam Ajzensztejn, Senior Director, ESG Reporting and Engagement, Teva Pharmaceutical Industries


  • BSI Group (British Standards Institution)

BSI shares knowledge, fosters innovation and instils best practice as a national standards body and founding member of ISO – International Standards Organization.

BSI is currently working on a programme of standards to align methodology to measure the carbon impact of pharmaceuticals. These standards are intended to serve as the common methodology across manufacturers to ensure comparability of results once submitted as evidence to healthcare systems.

Link to BSI brochure “Sustainable design and assessment of medicines”

Speaker: Courtney Soulsby, Global Director, Healthcare and Life Sciences sector team, BSI Group


Missed the webinar? Watch the recording below or watch it directly on our YouTube channel!

Watch the replay

Cover photo © PublicDomainPictures/Pixabay.